Literature DB >> 17622799

Molecular and structural transactions at human DNA replication origins.

Arturo Falaschi1, Gulnara Abdurashidova, Oscar Sandoval, Sorina Radulescu, Giuseppe Biamonti, Silvano Riva.   

Abstract

The DNA replication origins of metazoan genomes are the sites of complex sequence-specific protein-DNA interactions determining their precise cycle of activation and deactivation, once only along each cell cycle. Some of the involved proteins have been identified (and particularly the essential six-protein Origin Recognition Complex, ORC) thanks to their homology with the proteins identified in yeast. Whereas in the latter organism ORC has a specific affinity for an origin consensus, metazoan (and human) ORC shows no sequence specificity and no origin consensus is identifiable in their genomes. The modulation of topology around the origin sequence plays an essential role in the function of the human lamin B2 origin and the two topoisomerases interact specifically with it in a cell-cycle modulated way. The two enzymes are never present on the origin at the same time and compete, in different moments of the cell cycle, with the ORC2 subunit for the same sites in the origin area. The topoisomerases could give essential contributions to origin definition, as demonstrated by their capacity to bind specifically, in vitro the lamin B2 origin, either alone (topoisomerase I) or in a multi-protein complex (topoisomerase II). They also play critical roles in the origin activation-deactivation cycle, topoisomerase II probably contributing to attain and/or maintain a topological status fit for prereplicative complex assembly and topoisomerase I allowing the topological adaptations necessary for initiation of bi-directional synthesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17622799     DOI: 10.4161/cc.6.14.4495

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  17 in total

1.  DNA Topology and Topoisomerases: Teaching a "Knotty" Subject.

Authors:  Joseph E Deweese; Michael A Osheroff; Neil Osheroff
Journal:  Biochem Mol Biol Educ       Date:  2008       Impact factor: 1.160

2.  Acetylation of E2 by P300 Mediates Topoisomerase Entry at the Papillomavirus Replicon.

Authors:  Yanique Thomas; Elliot J Androphy
Journal:  J Virol       Date:  2019-03-21       Impact factor: 5.103

Review 3.  The use of divalent metal ions by type II topoisomerases.

Authors:  Joseph E Deweese; Neil Osheroff
Journal:  Metallomics       Date:  2010-05-21       Impact factor: 4.526

4.  Mammalian telomeres resemble fragile sites and require TRF1 for efficient replication.

Authors:  Agnel Sfeir; Settapong T Kosiyatrakul; Dirk Hockemeyer; Sheila L MacRae; Jan Karlseder; Carl L Schildkraut; Titia de Lange
Journal:  Cell       Date:  2009-07-10       Impact factor: 41.582

5.  Transient dsDNA breaks during pre-replication complex assembly.

Authors:  Emmanouil Rampakakis; Maria Zannis-Hadjopoulos
Journal:  Nucleic Acids Res       Date:  2009-07-28       Impact factor: 16.971

6.  Human initiation protein Orc4 prefers triple stranded DNA.

Authors:  J Kusic; B Tomic; A Divac; S Kojic
Journal:  Mol Biol Rep       Date:  2009-08-19       Impact factor: 2.316

7.  Metal ion interactions in the DNA cleavage/ligation active site of human topoisomerase IIalpha.

Authors:  Joseph E Deweese; F Peter Guengerich; Alex B Burgin; Neil Osheroff
Journal:  Biochemistry       Date:  2009-09-29       Impact factor: 3.162

Review 8.  The origin recognition complex: a biochemical and structural view.

Authors:  Huilin Li; Bruce Stillman
Journal:  Subcell Biochem       Date:  2012

9.  Use of divalent metal ions in the dna cleavage reaction of human type II topoisomerases.

Authors:  Joseph E Deweese; Amber M Burch; Alex B Burgin; Neil Osheroff
Journal:  Biochemistry       Date:  2009-03-10       Impact factor: 3.162

10.  Back to the origin: reconsidering replication, transcription, epigenetics, and cell cycle control.

Authors:  Adam G Evertts; Hilary A Coller
Journal:  Genes Cancer       Date:  2012-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.